Victoria’s Secret Reports Strong First-Quarter Results, Raises Full-Year Outlook
The company posted earnings of $0.60 per share and raised its full-year sales guidance by $120 million. Shares reached an all-time high after the results.
Victoria’s Secret reported first-quarter earnings of $0.60 per share, nearly double Wall Street expectations, and raised its full-year sales outlook by $120 million. Net sales rose 15 percent to $1.56 billion, exceeding company guidance. The company also increased its full-year adjusted operating income projection to between $550 million and $580 million.
Shares nearly doubled in price and reached an all-time high of $80 following the earnings release. The company changed its ticker symbol from VSCO to VSXY.
The chief executive said the company is reducing promotions and replacing them with emotional messaging aimed at full-price sales. Comparable sales posted their fourth consecutive quarter of growth, with double-digit increases in new customer acquisition. Executives attributed the results to higher regular-price selling and lower occupancy costs despite tariff pressures.
The company sources and manufactures across multiple countries, including Vietnam and Sri Lanka, and faces an estimated $90 million net tariff impact. An activist investor had questioned the chief executive’s ability to run a public company before the earnings release.
" — Chief executive, earnings call The company said its executive team has now worked together for roughly one year and described the turnaround as still in early stages.
Transparency
Story details
Related Stories
Iran's Supreme Leader Increasingly Active, Rubio Tells Congress
Marco Rubio told Congress on Tuesday that Iran's Supreme Leader Mojtaba Khamenei is increasingly engaged at some level. The testimony offered no details on the nature of the engagement or any policy steps.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…
U.S. Sanctions Iran's Largest Crypto Exchange Nobitex
U.S. officials imposed sanctions on Iran's largest cryptocurrency exchange Nobitex and three other Iranian platforms. The action targets Bitcoin and crypto trading operations linked to the country.